Literature DB >> 8844769

Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y.

W T Chance1, A Balasubramaniam, H Thompson, B Mohapatra, J Ramo, J E Fischer.   

Abstract

Tumor-bearing rats exhibited significant decreases in 1- to 4-h intake of rat chow following the intrahypothalamic injection of 2 micrograms neuropeptide Y (NPY). This refractory feeding response was present prior to the onset of anorexia and became more severe as anorexia worsened. The constant infusion of NPY (125 ng/h) into the perifornical hypothalamus of TB and control rats elicited increased feeding for only 2 days. Because chromatography revealed minipump NPY to be intact after 10 infusion days, downregulation of NPY receptors may have occurred. Daily injection of increasing doses of NPY stimulated ad lib feeding in non-TB rats, while having no effect on TB rats. Desensitization to NPY-induced feeding following daily injections of the peptide was suggested by the loss of feeding response to a dose (500 ng) of NPY that increased food intake prior to the daily NPY treatments. These results suggest that hypothalamic NPY feeding systems are refractory in TB rats, even before they exhibit anorexia. In addition, a rapid loss of the feeding response occurred in rats with constant infusion of NPY into hypothalamic tissue or with daily intrahypothalamic injections of the peptide, suggesting possible NPY receptor-mediated alterations. Therefore, control of obesity or anorexia through NPY feeding mechanisms may prove difficult due to rapid compensatory receptor changes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8844769     DOI: 10.1016/0196-9781(96)00108-8

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

Review 1.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 2.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

Review 3.  Neuropeptides in the pathophysiology and treatment of cachexia.

Authors:  Stephanie M Krasnow; Daniel L Marks
Journal:  Curr Opin Support Palliat Care       Date:  2010-12       Impact factor: 2.302

Review 4.  Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.

Authors:  Mitsuhiro Yoshimura; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2015-06-30       Impact factor: 2.781

5.  Site-specific attenuation of food intake but not the latency to eat after hypothalamic injections of neuropeptide Y in dehydrated-anorexic rats.

Authors:  Dawna Salter-Venzon; Alan G Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-09-09       Impact factor: 3.619

Review 6.  Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Biogerontology       Date:  2021-07-29       Impact factor: 4.277

7.  Pathophysiology and treatment of inflammatory anorexia in chronic disease.

Authors:  Theodore P Braun; Daniel L Marks
Journal:  J Cachexia Sarcopenia Muscle       Date:  2010-12-17       Impact factor: 12.910

8.  Cancer cachexia: mechanisms and clinical implications.

Authors:  Claire L Donohoe; Aoife M Ryan; John V Reynolds
Journal:  Gastroenterol Res Pract       Date:  2011-06-13       Impact factor: 2.260

Review 9.  Pathophysiology of anorexia in the cancer cachexia syndrome.

Authors:  Chukwuemeka Charles Ezeoke; John E Morley
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-10-27       Impact factor: 12.910

Review 10.  A review of nutrition and dietary interventions in oncology.

Authors:  Ashley Gray; Brian N Dang; Theodore B Moore; Roger Clemens; Peter Pressman
Journal:  SAGE Open Med       Date:  2020-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.